A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study

Published:2005-03 Issue:6 Volume:21 Page:739-746
ISSN:0269-2813
Container-title:Alimentary Pharmacology and Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Labenz J.,Armstrong D.,Lauritsen K.,Katelaris P.,Schmidt S.,Schutze K.,Wallner G.,Juergens H.,Preiksaitis H.,Keeling N.,Naucler E.,Eklund S.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2005.02368.x/fullpdf

Reference24 articles.

1. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

2. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines

3. Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

4. Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis;Journal of Clinical Medicine;2024-05-31

2. Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis;American Journal of Gastroenterology;2024-03-22

3. Potassium-competitive acid blockers and proton-pump inhibitors for healing of erosive esophagitis: a systematic review and network meta-analysis;Therapeutic Advances in Gastroenterology;2024-01

4. Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study;BMC Gastroenterology;2023-12-18

5. Efficacy and Safety of HIP1601 (Dual Delayed-release Esomeprazole) 40mg in Erosive Esophagitis Compared to HGP1705 (Delayed-release Esomeprazole) 40mg: A Multicenter, Randomized, Double-blind, Non-inferiority Study;2023-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3